Koers Regencell Bioscience Holdings Limited
Aandelen
RGC
KYG7487R1002
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,55 USD | +6,32% | +45,67% | -47,14% |
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 300 mln. 281 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -7 mln. -6,57 mln. | Nettowinst (verlies) 2023 | -5 mln. -4,69 mln. | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 15,65 mln. 14,69 mln. | Nettoliquiditeiten 2023 | 11,1 mln. 10,42 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-59,5
x | K/w-verhouding 2023 |
-51,1
x | Werknemers | 12 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 11,24% |
1 dag | +6,32% | ||
1 week | +45,67% | ||
Lopende maand | +23,33% | ||
1 maand | +37,04% | ||
3 maanden | -38,34% | ||
6 maanden | -68,21% | ||
Lopend jaar | -47,14% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Wai Hong Chung
COO | Chief Operating Officer | 46 | - |
Yi-Chung Chao
CTO | Chief Tech/Sci/R&D Officer | 59 | 01-10-20 |
Yat-Pui Au
PRN | Corporate Officer/Principal | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Wing Yan Lo
BRD | Director/Board Member | 63 | 13-12-21 |
Yi-Chung Chao
CTO | Chief Tech/Sci/R&D Officer | 59 | 01-10-20 |
- | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 5,55 | +6,32% | 1 338 |
18-04-24 | 5,22 | +10,18% | 11 218 |
17-04-24 | 4,738 | +27,70% | 8 531 |
15-04-24 | 3,71 | -2,62% | 2 857 |
12-04-24 | 3,81 | +0,26% | 1 411 |
uitgestelde koers Nasdaq, 19 april 2024 om 22:30 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-47,14% | 72,22 mln. | |
-1,42% | 41,52 mld. | |
+42,15% | 39,9 mld. | |
+1,97% | 38,83 mld. | |
-14,19% | 26,05 mld. | |
+1,82% | 23,78 mld. | |
-24,55% | 18,26 mld. | |
-4,07% | 11,65 mld. | |
+21,36% | 11,53 mld. | |
+8,20% | 11,2 mld. |